Innocoll Holdings Limited Resubmits New Drug Application to FDA for XARACOLL® for the Management of Postsurgical Pain after Open Inguinal Hernia Surgery

February 28, 2020

Innocoll Holdings Limited Resubmits New Drug Application to FDA for XARACOLL® for the Management of Postsurgical Pain after Open Inguinal Hernia Surgery
Read more
Alladapt Immunotherapeutics Secures $60 Million in Series C Financing for Development of Food Allergy Therapeutics

February 20, 2020

Alladapt Immunotherapeutics Secures $60 Million in Series C Financing for Development of Food Allergy Therapeutics
Read more
Before Brands

September 26, 2019

Nestlé Health Science invests in Before Brands, specialists in early childhood food allergy prevention and the inventors of SpoonfulOne™
Read more
Innocoll Holdings Limited Appoints Richard Fante as Chief Executive Officer

March 5, 2019

Innocoll Holdings Limited Appoints Richard Fante as Chief Executive Officer
Read more
Crossover Health Acquires Sherpaa Health Virtual Primary Care Platform

February 26, 2019

Crossover Health Acquires Sherpaa Health Virtual Primary Care Platform
Read more
Gurnet Point Capital Completes Tender Offer for Corium International, Transaction Valued in Excess of $500 Million

November 27, 2018

Gurnet Point Capital Completes Tender Offer for Corium International, Transaction Valued in Excess of $500 Million
Read more
Corium Announces Agreement for Gurnet Point Capital to Purchase All Outstanding Shares

October 15, 2018

Corium Announces Agreement for Gurnet Point Capital to Purchase All Outstanding Shares
Read more
Innocoll

July 25, 2017

Gurnet Point L.P. Completes Acquisition of Innocoll Holdings plc
Read more